Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
46.70
+0.40 (0.86%)
At close: Dec 5, 2025
-8.97%
Market Cap 857.20M
Revenue (ttm) 373.90M
Net Income (ttm) -2.89M
Shares Out 18.36M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE 53.68
Dividend n/a
Ex-Dividend Date n/a
Volume 17,576
Average Volume 36,649
Open 46.50
Previous Close 46.30
Day's Range 45.80 - 47.20
52-Week Range 26.50 - 53.50
Beta 0.03
RSI 64.27
Earnings Date Nov 9, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.